The correlations between BRCA1 defect and environmental factors in the risk of breast cancer

被引:14
作者
Kang, Hyo Jin [1 ]
Hong, Young Bin [1 ]
Yi, Yong Weon [1 ,3 ,4 ]
Cho, Chi-Heum [5 ]
Wang, Antai [6 ,7 ]
Bae, Insoo [1 ,2 ,3 ,4 ]
机构
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA
[2] Georgetown Univ, Dept Radiat Med, Lombardi Comprehens Canc Ctr, Washington, DC USA
[3] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea
[4] Dankook Univ, WCU World Class Univ Res Ctr Nanobiomed Sci, Cheonan, South Korea
[5] Keimyung Univ, Sch Med, Dept Obstet & Gynecol, Taegu, South Korea
[6] Columbia Univ, Dept Biostat, New York, NY USA
[7] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA
关键词
BRCA1; Genetic factor; Environmental factors; Tumorigenesis; Breast cancer; ARYL-HYDROCARBON RECEPTOR; OXIDATIVE STRESS; ADDUCT FORMATION; GENE-EXPRESSION; CELL-LINE; ACTIVATION; DNA; BENZO(A)PYRENE; METABOLISM; INDUCTION;
D O I
10.2131/jts.38.355
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The risk factors for breast cancer, the most common female malignant cancer, include environmental factors such as radiation, tobacco, a high-fat diet, and xenoestrogens as well as hormones. In addition, BRCA1 and BRCA2 are the most well-known genetic factors that increase risk for breast cancer. Coincidence of those environmental and genetic factors might augment the risk of tumorigenesis of breast. To verify this hypothesis, we briefly evaluated the carcinogenic potency of various environmental factors in the absence or presence of BRCA1 as a genetic factor in a normal mammary epithelial cell line, MCF10A. Many environmental factors tested increased cellular ROS level in the absence of other insult. In addition, TCDD, DMBA, 3MC, and BPA enhanced the BaP-induced ROS production. BRCA1 knockdown (BRCA1-KD) cells by siRNA significantly induced cellular accumulation of ROS compared to control cells. In this setting, the addition of paraquat, TCDD, DMBA, 2OHE2 or 4OHE2 significantly augmented ROS generation in BRCA1-KD MCF10A cells. Measurements of BaP-DNA adduct formation as a marker of DNA damage also revealed that BRCA1 deficiency leads increased DNA damage. In addition, TCDD and DMBA significantly increased BaP-DNA adduct formation in the absence of BRCA1 These results imply that elevated level of ROS is correlated with increase of DNA damage in BRCA1 defective cells. Taken together, our study suggests that several environmental factors might increase the risk of tumorigenesis in BRCA1 defective breast epithelial cells.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 50 条
  • [21] A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers
    Guinan, Emer M.
    Hussey, Juliette
    McGarrigle, Sarah A.
    Healy, Laura A.
    O'Sullivan, Jacintha N.
    Bennett, Kathleen
    Connolly, Elizabeth M.
    BMC CANCER, 2013, 13
  • [22] Parity and breast cancer risk among BRCA1 and BRCA2mutation carriers
    Antonis C Antoniou
    Andrew Shenton
    Eamonn R Maher
    Emma Watson
    Emma Woodward
    Fiona Lalloo
    Douglas F Easton
    D Gareth Evans
    Breast Cancer Research, 8
  • [23] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    Mainor, C. B.
    Isaacs, C.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (02) : 66 - 74
  • [24] Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Jane C. Figueiredo
    Robert W. Haile
    Jonine L. Bernstein
    Current Breast Cancer Reports, 2009, 1 (3) : 139 - 147
  • [25] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    C. B. Mainor
    C. Isaacs
    Current Breast Cancer Reports, 2020, 12 : 66 - 74
  • [26] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Henry T. Lynch
    Susan L. Neuhausen
    Parviz Ghadirian
    Claudine Isaacs
    Barbara Weber
    Charmaine Kim-Sing
    William D. Foulkes
    Ruth Gershoni-Baruch
    Peter Ainsworth
    Eitan Friedman
    Mary Daly
    Judy E. Garber
    Beth Karlan
    Olufunmilayo I. Olopade
    Nadine Tung
    Howard M. Saal
    Andrea Eisen
    Michael Osborne
    Hakan Olsson
    Dawna Gilchrist
    Ping Sun
    Steven A. Narod
    Cancer Causes & Control, 2005, 16 : 667 - 674
  • [27] Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Oden, Lovisa
    Akbari, Mohammad
    Zaman, Tasnim
    Singer, Christian F.
    Sun, Ping
    Narod, Steven A.
    Salmena, Leonardo
    Kotsopoulos, Joanne
    ONCOTARGET, 2016, 7 (52) : 86687 - 86694
  • [28] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Milne, Roger L.
    Osorio, Ana
    Ramon y Cajal, Teresa
    Baiget, Montserrat
    Lasa, Adriana
    Diaz-Rubio, Eduardo
    de la Hoya, Miguel
    Caldes, Trinidad
    Teule, Alex
    Lazaro, Conxi
    Blanco, Ignacio
    Balmana, Judith
    Sanchez-Olle, Gessami
    Vega, Ana
    Blanco, Ana
    Chirivella, Isabel
    Esteban Cardenosa, Eva
    Duran, Mercedes
    Velasco, Eladio
    Martinez de Duenas, Eduardo
    Tejada, Maria-Isabel
    Miramar, Maria-Dolores
    Calvo, Maria-Teresa
    Guillen-Ponce, Carmen
    Salazar, Raquel
    San Roman, Carlos
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (01) : 221 - 232
  • [29] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, J
    Lubinski, J
    Lynch, HT
    Neuhausen, SL
    Ghadirian, P
    Isaacs, C
    Weber, B
    Kim-Sing, C
    Foulkes, WD
    Gershoni-Baruch, R
    Ainsworth, P
    Friedman, E
    Daly, M
    Garber, JE
    Karlan, B
    Olopade, OI
    Tung, N
    Saal, HM
    Eisen, A
    Osborne, M
    Olsson, H
    Gilchrist, D
    Sun, P
    Narod, SA
    CANCER CAUSES & CONTROL, 2005, 16 (06) : 667 - 674
  • [30] Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Roger L. Milne
    Ana Osorio
    Teresa Ramón y Cajal
    Montserrat Baiget
    Adriana Lasa
    Eduardo Diaz-Rubio
    Miguel de la Hoya
    Trinidad Caldés
    Alex Teulé
    Conxi Lázaro
    Ignacio Blanco
    Judith Balmaña
    Gessamí Sánchez-Ollé
    Ana Vega
    Ana Blanco
    Isabel Chirivella
    Eva Esteban Cardeñosa
    Mercedes Durán
    Eladio Velasco
    Eduardo Martínez de Dueñas
    María-Isabel Tejada
    María-Dolores Miramar
    María-Teresa Calvo
    Carmen Guillén-Ponce
    Raquel Salazar
    Carlos San Román
    Miguel Urioste
    Javier Benítez
    Breast Cancer Research and Treatment, 2010, 119 : 221 - 232